Shiyue Mei
-
- MicroRNA in disease regulation 3
-
- Immune Response and Inflammation 4
- Immunotherapy and Immune Responses 3
-
- Metabolism and Genetic Disorders 6
-
- RNA modifications and cancer 7
- RNA Interference and Gene Delivery 4
-
- Genetics and Neurodevelopmental Disorders 12
- Genomics and Rare Diseases 9
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Shiyue Mei
33 papers receiving 382 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 124
- Immunology 106
- Clinical Biochemistry 32
- Molecular Biology 235
- Genetics 80
Countries citing papers authored by Shiyue Mei
This map shows the geographic impact of Shiyue Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyue Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyue Mei more than expected).
Fields of papers citing papers by Shiyue Mei
This network shows the impact of papers produced by Shiyue Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyue Mei. The network helps show where Shiyue Mei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shiyue Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 33 | |
| 16 | 2019 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2017 | 1 | |
| 19 | 2014 | 15 | |
| 20 | 2013 | 1 |
About Shiyue Mei
Shiyue Mei is a scholar working on Clinical Biochemistry, Genetics and Immunology, having authored 40 papers that have together received 385 indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (12 papers), Genomics and Rare Diseases (9 papers), RNA modifications and cancer (7 papers), Metabolism and Genetic Disorders (6 papers), RNA Interference and Gene Delivery (4 papers), Immune Response and Inflammation (4 papers), MicroRNA in disease regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (124 citations), Immunology (106 citations) and Clinical Biochemistry (32 citations). Shiyue Mei has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Rongcun Yang, Xiangdong Kong, Miaomiao Zhang, Xue Liang, Xiaomin Su, Shuang Hu, Hui Yan, Yongzhe Che, Yuan Zhang and Yu Liu. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.